New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2013
05:44 EDTCTICCell Therapeutics, GKV-SV reach agreement on pricing of Pixuvri in Germany
Cell Therapeutics announced that it concluded an agreement with the National Association of Statutory Health Insurance Funds, or GKV-Spitzenverband, in Germany for Pixuvri. Pixuvri is the first medicinal product approved in the European Union for patients with aggressive B-cell non-Hodgkin lymphoma who have failed two or three prior lines of therapy.
News For CTIC From The Last 14 Days
Check below for free stories on CTIC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CTIC

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use